Hohimer Wealth Management LLC Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hohimer Wealth Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 23.7% in the third quarter, Holdings Channel reports. The firm owned 9,429 shares of the healthcare conglomerate’s stock after buying an additional 1,808 shares during the quarter. UnitedHealth Group accounts for about 1.2% of Hohimer Wealth Management LLC’s portfolio, making the stock its 15th biggest position. Hohimer Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,513,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the stock. Benjamin Edwards Inc. boosted its stake in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $21,165,000. Tealwood Asset Management Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $2,905,000. Kestra Investment Management LLC bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $5,554,000. Finally, Coldstream Capital Management Inc. raised its position in shares of UnitedHealth Group by 6.5% during the 3rd quarter. Coldstream Capital Management Inc. now owns 26,722 shares of the healthcare conglomerate’s stock valued at $15,653,000 after purchasing an additional 1,627 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.8 %

NYSE:UNH opened at $565.39 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a fifty day simple moving average of $586.36 and a 200-day simple moving average of $559.39. The company has a market cap of $520.31 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the company posted $6.56 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on UNH shares. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. TD Cowen increased their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.